Gene Disruption of Tissue Transglutaminase

No abstract is available for this paper.

• Publication year

  2001

• Venue

  Molecular and Cellular Biology

• Publication date

  2001-01-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1128/MCB.21.1.148-155.2001PMID 11113189PMCID PMC88788
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Assays for transglutaminases in cell death.

  2000cited by this paper
• Apoptosis: The little devil of death

  2000cited by this paper
• Differential Expression of Multiple Transglutaminases in Human Brain

  1999cited by this paper
• Induction of apoptosis by IFNγ in human neuroblastoma cell lines through the CD95/CD95L autocrine circuit

  1999cited by this paper
• Identification of ‘tissue’ transglutaminase binding proteins in neural cells committed to apoptosis

  1999cited by this paper
• Tissue transglutaminase: apoptosis versus autoimmunity.

  1999cited by this paper
• Transglutaminase crosslinking and structural studies of the human small proline rich 3 protein

  1999cited by this paper
• Apaf1 and the apoptotic machinery

  1999cited by this paper
• Caspase knockouts: matters of life and death

  1999cited by this paper
• Mechanisms mediating caspase activation in cell death

  1999cited by this paper
• Expression of tissue transglutaminase in the developing chicken limb is associated both with apoptosis and endochondral ossification

  1999cited by this paper
• Transglutaminase 1 Mutations in Lamellar Ichthyosis

  1998cited by this paper
• Identification of a Transforming Growth Factor-β1/Bone Morphogenetic Protein 4 (TGF-β1/BMP4) Response Element within the Mouse Tissue Transglutaminase Gene Promoter*

  1998cited by this paper
• Transglutaminase action imitates Huntington's disease: selective polymerization of Huntingtin containing expanded polyglutamine.

  1998cited by this paper
• DRPLA aggregation and transglutaminase, revisited

  1998cited by this paper
• Suppression of aggregate formation and apoptosis by transglutaminase inhibitors in cells expressing truncated DRPLA protein with an expanded polyglutamine stretch

  1998cited by this paper
• Defective stratum corneum and early neonatal death in mice lacking the gene for transglutaminase 1 (keratinocyte transglutaminase).

  1998cited by this paper
• Huntingtin acts in the nucleus to induce apoptosis but death does not correlate with the formation of intranuclear inclusions.

  1998cited by this paper
• `Tissue' transglutaminase in cell death: a downstream or a multifunctional upstream effector?

  1998cited by this paper
• Tissue transglutaminase selectively modifies gliadin peptides that are recognized by gut-derived T cells in celiac disease

  1998cited by this paper
• Lack of ‘tissue’ transglutaminase protein cross-linking leads to leakage of macromolecules from dying cells: relationship to development of autoimmunity in MRLlpr/lpr mice

  1997cited by this paper
• Identification of tissue transglutaminase as the autoantigen of celiac disease

  1997cited by this paper
• Retinoic Acid Receptors α and γ Mediate the Induction of “Tissue” Transglutaminase Activity and Apoptosis in Human Neuroblastoma Cells☆

  1997cited by this paper
• S-nitrosylation regulates apoptosis

  1997cited by this paper
• Retinoic acid receptors alpha and gamma mediate the induction of "tissue" transglutaminase activity and apoptosis in human neuroblastoma cells.

  1997cited by this paper
• The promoter of the mouse tissue transglutaminase gene directs tissue-specific, retinoid-regulated and apoptosis-linked expression

  1997cited by this paper
• Differential expression of tissue transglutaminase during in vivo apoptosis of thymocytes induced via distinct signalling pathways

  1997cited by this paper
• DIFFERENTIAL GROWTH OF N‐ AND S‐TYPE HUMAN NEUROBLASTOMA CELLS XENOGRAFTED INTO SCID MICE. CORRELATION WITH APOPTOSIS

  1996cited by this paper
• Expression and activation of tissue transglutaminase in apoptotic cells of involuting rodent mammary tissue.

  1996cited by this paper
• Tissue transglutaminase expression in human breast cancer.

  1996cited by this paper
• Induction of "tissue" transglutaminase in HIV pathogenesis: evidence for high rate of apoptosis of CD4+ T lymphocytes and accessory cells in lymphoid tissues.

  1996cited by this paper
• Identification and Characterization of a Versatile Retinoid Response Element (Retinoic Acid Receptor Response Element-Retinoid X Receptor Response Element) in the Mouse Tissue Transglutaminase Gene Promoter (*)

  1996cited by this paper
• Mutations in the gene for transglutaminase 1 in autosomal recessive lamellar ichthyosis

  1995cited by this paper
• A model for the hierarchical structure of the human epidermal cornified cell envelope.

  1995cited by this paper
• Evidence for the Involvement of Retinoic Acid Receptor RAR-dependent Signaling Pathway in the Induction of Tissue Transglutaminase and Apoptosis by Retinoids (*)

  1995cited by this paper
• Mutations of keratinocyte transglutaminase in lamellar ichthyosis

  1995cited by this paper
• Altered cytokine export and apoptosis in mice deficient in interleukin-1 beta converting enzyme.

  1995cited by this paper
• Mice deficient in IL-1 beta-converting enzyme are defective in production of mature IL-1 beta and resistant to endotoxic shock.

  1995cited by this paper
• Tissue transglutaminase: a candidate effector element of physiological cell death.

  1995cited by this paper
• Gh: a GTP-binding protein with transglutaminase activity and receptor signaling function.

  1994cited by this paper
• Immunohistochemical localization of tissue transglutaminase and Bcl-2 in rat uterine tissues during embryo implantation and post-partum involution.

  1994cited by this paper
• Tissue transglutaminase and apoptosis: sense and antisense transfection studies with human neuroblastoma cells

  1994cited by this paper
• Multiple cell cycle access to the apoptotic death programme in human neuroblastoma cells

  1993cited by this paper
• Phenotype‐specific “tissue” transglutaminase regulation in human neuroblastoma cells in response to retinoic acid: Correlation with cell death by apoptosis

  1992cited by this paper
• Apoptotic cell death and tissue remodelling during mouse mammary gland involution.

  1992cited by this paper
• Mice deficient for p53 are developmentally normal but susceptible to spontaneous tumours

  1992cited by this paper
• Apoptosis: molecular mechanisms in programmed cell death.

  1991cited by this paper
• Neonatal lethality and lymphopenia in mice with a homozygous disruption of the c-abl proto-oncogene.

  1991cited by this paper
• The expression of "tissue" transglutaminase in two human cancer cell lines is related with the programmed cell death (apoptosis).

  1991cited by this paper
• Apoptotic hepatocytes become insoluble in detergents and chaotropic agents as a result of transglutaminase action

  1989cited by this paper
• Correlation between transglutaminase activity and polyamine levels in human neuroblastoma cells. Effect of retinoic acid and alpha-difluoromethylornithine.

  1988cited by this paper
• Identification of a guanosine triphosphate-binding site on guinea pig liver transglutaminase. Role of GTP and calcium ions in modulating activity.

  1987cited by this paper

• Peyer's patch B cells sample transglutaminase-gluten complexes and drive celiac disease autoimmunity.

  2025cites this paper
• MMP-9 regulates disulphide isomerase activity of TGM2 to enhance fusion glycoprotein-mediated syncytium formation of respiratory syncytial virus

  2025cites this paper
• Critical Role for Transglutaminase 2 in Scleroderma Skin Fibrosis and in the Development of Dermal Sclerosis in a Mouse Model of Scleroderma

  2025cites this paper
• Selective activation of naïve B cells with unique epitope specificity shapes autoantibody formation in celiac disease.

  2024cites this paper
• Deletion of Tgm2 suppresses BMP‐mediated hepatocyte‐to‐cholangiocyte metaplasia in ductular reaction

  2024cites this paper
• Enterocyte-Derived and Catalytically Active Transglutaminase 2 in the Gut Lumen of Mice: Implications for Celiac Disease

  2024cites this paper
• Transcriptomics studies reveal functions of Transglutaminase 2 in breast cancer cells using membrane permeable and impermeable inhibitors.

  2024cites this paper
• Increased Osteoclastogenesis in Absence of TG2 Is Reversed by Transglutaminase Inhibition—Evidence for the Role for TG1 in Osteoclast Formation

  2023cites this paper
• Muc2-dependent microbial colonization of the jejunal mucus layer is diet sensitive and confers local resistance to enteric pathogen infection

  2023cites this paper
• Autoimmune amelogenesis imperfecta in patients with APS-1 and coeliac disease

  2023cites this paper
• Extracellular transglutaminase-2, nude or associated with astrocytic extracellular vesicles, modulates neuronal calcium homeostasis.

  2022cites this paper
• Naturally Occurring Epsilon Gamma Glutamyl Lysine Isopeptide Crosslinks in Human Neuroblastoma SH-SY5Y Cells

  2022cites this paper
• Absence of tissue transglutaminase reduces amyloid‐beta pathology in APP23 mice

  2022cites this paper
• The Transglutaminase-2 Interactome in the APP23 Mouse Model of Alzheimer’s Disease

  2022cites this paper
• Glutamine prevents acute kidney injury by modulating oxidative stress and apoptosis in tubular epithelial cells

  2022cites this paper
• Resolution of Eczema with Multivalent Peptides

  2022cites this paper
• Latent TGFβ complexes are transglutaminase cross-linked to fibrillin to facilitate TGFβ activation

  2022cites this paper
• Transglutaminase 3 crosslinks the secreted gel-forming mucus component Mucin-2 and stabilizes the colonic mucus layer

  2022cites this paper
• Injection of prototypic celiac anti-transglutaminase 2 antibodies in mice does not cause enteropathy

  2022cites this paper
• Features of ZED1227: The First-In-Class Tissue Transglutaminase Inhibitor Undergoing Clinical Evaluation for the Treatment of Celiac Disease

  2022cites this paper
• Implications of enigmatic transglutaminase 2 (TG2) in cardiac diseases and therapeutic developments.

  2022cites this paper
• Tissue Transglutaminase Knock-Out Preadipocytes and Beige Cells of Epididymal Fat Origin Possess Decreased Mitochondrial Functions Required for Thermogenesis

  2022cites this paper
• LRP-1 links post-translational modifications to efficient presentation of celiac disease-specific T cell antigens.

  2022cites this paper
• TG2-gluten complexes as antigens for gluten-specific and transglutaminase-2 specific B cells in celiac disease

  2021cites this paper
• Transglutaminase 3 crosslinks secreted MUC2 and stabilizes the colonic mucus layer

  2021cites this paper
• Possible Roles of the Transglutaminases in the Molecular Mechanisms Responsible for Human Neurological Diseases

  2021cites this paper
• TGFβ1-Induced Transglutaminase-2 Triggers Catabolic Response in Osteoarthritic Chondrocytes by Modulating MMP-13

  2021cites this paper
• Transglutaminase 2 mediates UVB‐induced matrix metalloproteinase‐1 expression by inhibiting nuclear p65 degradation in dermal fibroblasts

  2021cites this paper
• A Multi-Omics Approach Using a Mouse Model of Cardiac Malformations for Prioritization of Human Congenital Heart Disease Contributing Genes

  2021cites this paper
• Transglutaminase 2 as a Marker for Inflammation and Therapeutic Target in Sepsis

  2021cites this paper
• Tranglutaminase 2 contributes to the asthmatic inflammation by modulating activation of alveolar macrophages

  2021cites this paper
• Impaired Skeletal Muscle Development and Regeneration in Transglutaminase 2 Knockout Mice

  2021cites this paper
• Transglutaminase 2: Development of therapeutic antibodies reveals four inhibitory epitopes and confirms extracellular function in fibrotic remodelling

  2021cites this paper
• Astrocytic extracellular vesicles modulate neuronal calcium homeostasis via transglutaminase-2

  2021cites this paper
• Transglutaminase 2 mediates transcriptional regulation through BAF250a polyamination

  2021cites this paper
• Transglutaminase 2 mediates lung inflammation and remodeling by transforming growth factor beta 1 via alveolar macrophage modulation

  2021cites this paper
• A Precision Strategy to Cure Renal Cell Carcinoma by Targeting Transglutaminase 2

  2020cites this paper
• Keratinocyte transglutaminase 2 promotes CCR6+ γδT-cell recruitment by upregulating CCL20 in psoriatic inflammation

  2020cites this paper
• Transglutaminase 2 Has Metabolic and Vascular Regulatory Functions Revealed by In Vivo Activation of Alpha1-Adrenergic Receptor

  2020cites this paper
• Az apoptotikus és nekrotikus sejtek makrofágok általi eltakarításának és a transzglutamináz 2 vázizom nekrózist követő regenerációban betöltött szerepének vizsgálata

  2020cites this paper
• Transglutaminase 3 Reduces the Severity of Psoriasis in Imiquimod-Treated Mouse Skin

  2020cites this paper
• Transglutaminase 2 as a novel target in chronic kidney disease - Methods, mechanisms and pharmacological inhibition.

  2020cites this paper
• Transglutaminase Type 2 is Involved in the Hematopoietic Stem Cells Homeostasis

  2020cites this paper
• B cell tolerance and antibody production to the celiac disease autoantigen transglutaminase 2

  2019cites this paper
• The role of transglutaminase 2 in mediating glial cell function and pathophysiology in the central nervous system.

  2019cites this paper
• Spotlight on the Transglutaminase 2-Heparan Sulfate Interaction

  2019cites this paper
• Transglutaminase diseases: from biochemistry to the bedside

  2019cites this paper
• Loss of transglutaminase 2 sensitizes for diet-induced obesity-related inflammation and insulin resistance due to enhanced macrophage c-Src signaling

  2019cites this paper
• Transglutaminases in autoimmune and inherited skin diseases: The phenomena of epitope spreading and functional compensation

  2018cites this paper
• Pluripotency and a secretion mechanism of Drosophila transglutaminase

  2018cites this paper
• In vivo evaluation of two tissue transglutaminase PET tracers in an orthotopic tumour xenograft model

  2018cites this paper
• Microglial transglutaminase-2 drives myelination and myelin repair via GPR56/ADGRG1 in oligodendrocyte precursor cells

  2018cites this paper
• Spotlight on the transglutaminase 2 gene: a focus on genomic and transcriptional aspects.

  2018cites this paper
• S-nitrosylation of transglutaminase 2 impairs fatty acid-stimulated contraction in hypertensive cardiomyocytes

  2018cites this paper
• Transglutaminase Type 2 Regulates ER-Mitochondria Contact Sites by Interacting with GRP75.

  2018cites this paper
• Proteomic Profiling Reveals the Transglutaminase-2 Externalization Pathway in Kidneys after Unilateral Ureteric Obstruction.

  2018cites this paper
• TG2 regulates the heat‐shock response by the post‐translational modification of HSF1

  2018cites this paper
• Pharmacologic inhibition of the enzymatic effects of tissue transglutaminase reduces cardiac fibrosis and attenuates cardiomyocyte hypertrophy following pressure overload.

  2018cites this paper
• Opening up about Tissue Transglutaminase: When Conformation Matters More than Enzymatic Activity

  2018cites this paper
• Renal Cell Carcinoma Is Abrogated by p53 Stabilization through Transglutaminase 2 Inhibition

  2018cites this paper
• The diamond anniversary of tissue transglutaminase: a protein of many talents.

  2018cites this paper
• Non-alcoholic fatty liver disease severity is modulated by transglutaminase type 2

  2018cites this paper
• Tissue transglutaminase in the pathogenesis of heart failure

  2017cites this paper
• Astrocyte-derived tissue Transglutaminase affects fibronectin deposition, but not aggregation, during cuprizone-induced demyelination

  2017cites this paper
• Transglutaminase 2 regulates osteoclast differentiation via a Blimp1-dependent pathway

  2017cites this paper
• Transglutaminase 2 mediates UV-induced skin inflammation by enhancing inflammatory cytokine production

  2017cites this paper
• Computational investigation of small-molecule human tissue transglutaminase inhibitors

  2017cites this paper
• Transglutaminase inhibition: possible therapeutic mechanisms to protect cells from death in neurological disorders

  2017cites this paper
• Tissue transglutaminase induction in the pressure-overloaded myocardium regulates matrix remodelling

  2017cites this paper
• Browning deficiency and low mobilization of fatty acids in gonadal white adipose tissue leads to decreased cold-tolerance of transglutaminase 2 knock-out mice.

  2017cites this paper
• Possible roles of transglutaminases in molecular mechanisms responsible for cancer and human neurodegenerative diseases

  2017cites this paper
• Mineralization-inhibiting effects of transglutaminase-crosslinked polymeric osteopontin.

  2017cites this paper
• Transglutaminases factor XIII-A and TG2 regulate resorption, adipogenesis and plasma fibronectin homeostasis in bone and bone marrow

  2017cites this paper
• Reovirus infection triggers inflammatory responses to dietary antigens and development of celiac disease

  2017cites this paper
• Animal protocols: Animal experiments were conducted in accordance with the National Institutes of Health Guide for the Care and Use of Laboratory Animals and were approved by the Baylor College of Medicine and Albert Einstein College of Medicine Institutional Review

  2017cites this paper
• Transglutaminase 2, a double face enzyme

  2017influential citation
• Transglutaminase 2 is dispensable but required for the survival of mice in dextran sulfate sodium-induced colitis

  2016cites this paper
• eview ascular ageing and endothelial cell senescence : Molecular echanisms of physiology and diseases

  2016cites this paper
• Thioredoxin-1 Selectively Activates Transglutaminase 2 in the Extracellular Matrix of the Small Intestine

  2016cites this paper
• Vascular ageing and endothelial cell senescence: Molecular mechanisms of physiology and diseases.

  2016cites this paper
• In situ enzymatic activity of transglutaminase isoforms on brain tissue sections of rodents: A new approach to monitor differences in post-translational protein modifications during neurodegeneration.

  2016cites this paper
• Transglutaminase 2 in cartilage homoeostasis: novel links with inflammatory osteoarthritis

  2016cites this paper
• P2X7 receptor-mediated TG2 externalization: a link to inflammatory arthritis?

  2016cites this paper
• The role of transglutaminases in the development of abdominal aortic aneurysms

  2016cites this paper
• Transglutaminase is a Critical Link Between Inflammation and Hypertension

  2016cites this paper
• Transglutaminase Activity as a Possible Molecular Mechanism in the Etiopathogenesis of Neurodegenerative Diseases

  2016cites this paper
• Discovery of a novel target for renal cell carcinoma: transglutaminase 2

  2016cites this paper
• Multivalent pIX phage display selects for distinct and improved antibody properties

  2016cites this paper
• Transglutaminase 2 strongly binds to an extracellular matrix component other than fibronectin via its second C‐terminal beta‐barrel domain

  2016cites this paper
• Characterization of TG2 and TG1–TG2 double knock-out mouse epidermis

  2016cites this paper
• Transglutaminase 2 in cartilage homoeostasis: novel links with inflammatory osteoarthritis

  2016cites this paper
• Development of carbon-11 labeled acryl amides for selective PET imaging of active tissue transglutaminase.

  2016cites this paper
• The interaction of heparan sulfate proteoglycans with endothelial transglutaminase-2 limits VEGF165-induced angiogenesis

  2015cites this paper
• Transglutaminase 2-Mediated Gene Regulation

  2015cites this paper
• Transglutaminase 2 interactions with extracellular matrix proteins as probed with celiac disease autoantibodies

  2015cites this paper
• Possible pathophysiological roles of transglutaminase-catalyzed reactions in the pathogenesis of human neurodegenerative diseases

  2015cites this paper
• Transglutaminases: Expression in Kidney and Relation to Kidney Fibrosis

  2015cites this paper
• Tissue Transglutaminase contributes to experimental multiple sclerosis pathogenesis and clinical outcome by promoting macrophage migration.

  2015cites this paper
• Insights into Transglutaminase 2 Function Gained from Genetically Modified Animal Models

  2015cites this paper
• Possible Role of the Transglutaminase Activity in Molecular Mechanisms Responsible for Human Neurodegenerative Diseases

  2015cites this paper